This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Victory Square Technologies Reports...
Business earnings report

Victory Square Technologies Reports Strong 2025 Results

Analysis based on 6 articles · First reported May 01, 2026 · Last updated May 01, 2026

Sentiment
70
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The positive fiscal 2025 results from Victory Square Technologies, driven by the strong performance of Hydreight Technologies Inc., are expected to positively impact investor sentiment towards Victory Square Technologies and its portfolio companies. The reported revenue growth and improved operating leverage suggest a strong financial position and future growth potential in the digital health and technology sectors.

healthcare venture capital artificial intelligence
Event Summary

Victory Square Technologies Inc. reported its audited financial results for the year ended December 31, 2025, highlighting a transition year with strong performance from its subsidiary Hydreight Technologies Inc. Hydreight Technologies Inc. achieved record growth and profitability, with revenue increasing to $35.4 million in 2025 from $16.04 million in 2024, and improved operating leverage. The company also provided updates on its portfolio, including the expansion of the VSDHOne healthcare platform, the development of Insu Therapeutics' buccal delivery system for peptide-based therapies, and the launch of a venture fund and incubator by Pawsible Ventures in the pet health sector. Additionally, Victory Square Technologies dividended shares of Arash Asli Inc. to its shareholders, demonstrating its capital allocation model.

Entities Involved
stock
Victory Square Technologies
Victory Square Technologies reported strong fiscal 2025 results, driven by its subsidiary Hydreight Technologies Inc., and provided updates on its portfolio companies, indicating significant growth and improved operating efficiency.
Importance 100.0 Sentiment 75.0
per
Shafin Diamond Tejani
Shafin Diamond Tejani, Chairman and CEO of Victory Square Technologies, provided commentary on the company's strong performance and strategic focus on building scalable systems across its portfolio.
Importance 60.0 Sentiment 70.0
priv
Insu Therapeutics
Insu Therapeutics is developing a proprietary buccal delivery system for peptide-based therapies, complementing Hydreight Technologies' infrastructure by providing next-generation payload innovation.
Importance 40.0 Sentiment 60.0
priv
Pawsible Ventures
Pawsible Ventures, a portfolio company of Victory Square Technologies, is expanding its platform in the pet health sector, launching a venture fund, studio, and incubator in 2026.
Importance 30.0 Sentiment 50.0
priv
Arash Asli
Victory Square Technologies dividended Class A common shares of Arash Asli Inc. to its shareholders, reflecting its capital allocation model of monetization.
Importance 20.0 Sentiment 50.0
priv
Hydreight Technologies
Importance 0 Sentiment 0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.